NCT07337356

Brief Summary

Delirium has a high incidence rate and significantly affects patient prognosis. Diagnosis often relies on manual assessment, which is subject to strong subjectivity, high rates of missed diagnosis, and poor stability. This study employs non-contact identification technology based on machine vision analysis to quantitatively analyze characteristic biological feature data such as micro-expressions. It then investigates the correlation between these features and delirium subtypes. By integrating clinical phenotypic data and using machine learning algorithms, a multi-modal early prediction model for delirium is constructed to meet the clinical need for early warning of delirium subtypes and enhance the efficacy of delirium identification.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
795

participants targeted

Target at P75+ for all trials

Timeline
9mo left

Started Feb 2026

Shorter than P25 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress26%
Feb 2026Feb 2027

First Submitted

Initial submission to the registry

January 4, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 13, 2026

Completed
19 days until next milestone

Study Start

First participant enrolled

February 1, 2026

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2027

Last Updated

January 13, 2026

Status Verified

December 1, 2025

Enrollment Period

7 months

First QC Date

January 4, 2026

Last Update Submit

January 4, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Number of participants with delirium as assessed by DSM-5

    Zero is equivalent to no delirium and a high score means a higher occurrence of delirium

    7th day after ICU admission

Secondary Outcomes (4)

  • Accuracy

    7th day after ICU admission

  • Precision

    7th day after ICU admission

  • Recall

    7th day after ICU admission

  • F1-score

    7th day after ICU admission

Study Arms (2)

observational

1. Meets the delirium diagnostic criteria specified in the Diagnostic and Statistical Manual of Mental Disorders (5th Edition) (DSM-5), which requires the concurrent presence of: ① disturbance in awareness (reduced clarity of awareness of the environment) ; ② change in cognition (e.g., memory impairment, disorientation); 2. Undergoes consecutive daily assessments for 7 days using the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) at three time points (8:00, 14:00, 20:00) with an interval of ≥ 6 hours between each assessment, with at least two positive results;

control

Admitted to the ICU during the same period, with negative results on consecutive daily CAM-ICU assessments for 3 days (three assessments per day as the observational group).

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patients (≥18 years old) admitted to the ICU of Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, including elderly patients, those post-surgery, with sepsis, and trauma, which are common high-risk populations for delirium.

You may qualify if:

  • Age ≥ 18 years, expected ICU stay ≥ 24 hours, and informed consent to participate in this study;

You may not qualify if:

  • Patients with severe facial trauma/deformities that prevent complete expression acquisition, and patients with a history of emotional problems (such as anxiety, depression, etc.).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Delirium

Condition Hierarchy (Ancestors)

ConfusionNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeurocognitive DisordersMental Disorders

Central Study Contacts

weiqing Zhang Ph.D, Ph.D

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Target Duration
7 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 4, 2026

First Posted

January 13, 2026

Study Start

February 1, 2026

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

February 1, 2027

Last Updated

January 13, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share